T. Mettang et al., UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 11(12), 1996, pp. 2439-2443
Uraemic pruritus is a frequent and disabling symptom in patients on di
alysis. The pathogenesis of uraemic pruritus is nevertheless still obs
cure. We investigated whether di(2-ethylhexyl)phthalate (DEHP), the mo
st commonly used plasticizer in polyvinylchloride (PVC) haemodialysis
tubings, is a possible pathogenetic factor in uraemic pruritus. Serum
concentrations of DEHP and its major derivatives mono-(2-ethylhexyl)ph
thalate (MEHP), 2-ethylhexanol (2-EH) and phthalic acid (PA) were dete
rmined in uraemic patients before and after a haemodialysis session an
d compared with the occurrence and intensity of pruritus in these pati
ents. Twenty-one patients on regular haemodialysis for at least 6 mont
hs were examined. The severity of uraemic pruritus was assessed using
a standard questionnaire (pruritus score). The quantitative analysis o
f DEHP and its derivatives was carried out by GC/selected ion monitori
ng mass spectrometry. Fourteen out of 21 patients (66%) complained abo
ut uraemic pruritus to a variable degree. The post-dialysis serum conc
entrations of DEHP, MEHP and 2-EH were significantly higher than the c
orresponding pre-dialysis values, whereas the postdialysis concentrati
ons of PA (0.122 +/- 0.078 mu g/ml) were significantly lower than pre-
dialysis levels (0.194 +/- 0.101 mu g/ml, P=0.00068). Neither pre- nor
post-dialysis serum concentrations of DEHP, MEHP, PA or 2-EH were cor
related with the severity of uraemic pruritus. Additionally, serum con
centrations of DEHP and its metabolites did not differ significantly i
n patients with and without pruritus. These findings suggest that pati
ents on haemodialysis are regularly exposed to considerable amounts of
DEHP and metabolites. Phthalic acid, one of the presumed end products
of DEHP metabolism, might be eliminated at least in part by haemodial
ysis. The exposition to DEHP and metabolites during haemodialysis, as
assessed by measuring serum concentrations, bears no immediate relatio
n to the occurrence or intensity of uraemic pruritus.